Evidence map›Paper›PMID 24391495›Full record

ArticlePLoS pathogens2014

Characterisation of a multi-ligand binding chemoreceptor CcmL (Tlp3) of Campylobacter jejuni.

Hossinur Rahman, Rebecca M King, Lucy K Shewell, Evgeny A Semchenko, Lauren E Hartley-Tassell, Jennifer C Wilson, Christopher J Day, Victoria Korolik

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Insights into Chemoreceptor MCP2201-Sensing D-Malate.International journal of molecular sciences · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Molecular Targets inBiomolecules · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Signal binding at both modules of its dCache domain enables the McpA chemoreceptor ofProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. TheMicroorganisms · 2021
    Article
  18. Antibiofilm Potential ofApplied and environmental microbiology · 2021
    Article
  19. Article
  20. TheScience signaling · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hossinur RahmanInstitute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Australia.
Rebecca M KingInstitute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Australia.
Lucy K ShewellInstitute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Australia.
Evgeny A SemchenkoInstitute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Australia.
Lauren E Hartley-TassellInstitute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Australia.
Jennifer C WilsonInstitute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Australia.
Christopher J DayInstitute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Australia.
Victoria KorolikInstitute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Australia.
Griffith University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Campylobacter jejuni is the leading cause of human gastroenteritis worldwide with over 500 million cases annually. Chemotaxis and motility have been identified as important virulence factors associated with C. jejuni colonisation. Group A transducer-like proteins (Tlps) are responsible for sensing the external environment for bacterial movement to or away from a chemical gradient or stimulus. In this study, we have demonstrated Cj1564 (Tlp3) to be a multi-ligand binding chemoreceptor and report direct evidence supporting the involvement of Cj1564 (Tlp3) in the chemotaxis signalling pathway via small molecule arrays, surface plasmon and nuclear magnetic resonance (SPR and NMR) as well as chemotaxis assays of wild type and isogenic mutant strains. A modified nutrient depleted chemotaxis assay was further used to determine positive or negative chemotaxis with specific ligands. Here we demonstrate the ability of Cj1564 to interact with the chemoattractants isoleucine, purine, malic acid and fumaric acid and chemorepellents lysine, glucosamine, succinic acid, arginine and thiamine. An isogenic mutant of cj1564 was shown to have altered phenotypic characteristics of C. jejuni, including loss of curvature in bacterial cell shape, reduced chemotactic motility and an increase in both autoagglutination and biofilm formation. We demonstrate Cj1564 to have a role in invasion as in in vitro assays the tlp3 isogenic mutant has a reduced ability to adhere and invade a cultured epithelial cell line; interestingly however, colonisation ability of avian caeca appears to be unaltered. Additionally, protein-protein interaction studies revealed signal transduction initiation through the scaffolding proteins CheV and CheW in the chemotaxis sensory pathway. This is the first report characterising Cj1564 as a multi-ligand receptor for C. jejuni, we therefore, propose to name this receptor CcmL, Campylobacter chemoreceptor for multiple ligands. In conclusion, this study identifies a novel multifunctional role for the C. jejuni CcmL chemoreceptor and illustrates its involvement in the chemotaxis pathway and subsequent survival of this organism in the host.

Indexed as

AnimalsBacterial ProteinsBiofilmsCaco-2 CellsCampylobacter InfectionsCampylobacter jejuniChickensGastroenteritisHumansSignal TransductionBacterial Proteins

Identifiers

PMID24391495
PMCPMC3879368
OpenAlexW2018027663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.